Vinod BalachandranMD
@TheVinodLab
Followers
5K
Following
1K
Media
70
Statuses
779
Founding Director Olayan Center for Cancer Vaccines @MSKCancerCenter | Cancer Surgeon-Scientist | Pancreas cancer | Cancer immunology | 2x dad, 2x ironman
New York, NY
Joined June 2017
RT @MyriamChalabi: Fascinating data and excellent presentation on PDAC . RNA neoantigen vaccines by @TheVinodLab #ESMOGI25 full paper: http….
0
17
0
RT @themis_brown: Excited to share our study describing a role for a subset of Thetis cells, TC IV, in tolerance to food antigens. A team e….
science.org
In the intestine, peripherally induced regulatory T (pTreg) cells play an essential role in suppressing inflammatory responses to food proteins. However, the identity of the antigen-presenting cells...
0
20
0
Congratulations @themis_brown! Fantastic!!.
Yet more brilliance from @themis_brown - its been a joy to have a front-row seat watching her group essentially rewrite the textbook on early life immunity. Kudos to one of the best scientists and human beings that I am fortuate to know!.
1
0
4
RT @aspenideas: 💡 Vinod Balachandran, Director of the Olayan Center for Cancer Vaccines at @MSKCancerCenter, will explain how mRNA vaccine….
0
2
0
Grateful & humbled to make the 2025 #TIME100HEALTH list with such inspiring global health leaders. This honor reflects my team, who are unrelenting in their efforts to advance new treatments for pancreatic cancer!.
TIME's new cover: Meet this year's #TIME100Health, a community of leaders—scientists, doctors, advocates, educators, and policy-makers, among others—who are changing the health of the world.
9
10
90
RT @MSKCancerCenter: MSK researchers are trying to understand how the immune system senses cancer in order to make better #immunotherapies.….
0
7
0
RT @ScienceNews: A new mRNA vaccine could prevent pancreatic cancer from returning — potentially for the long haul.
sciencenews.org
A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.
0
193
0
RT @DrVickersMSK: I am moved by the passion and expertise of the remarkable team at the Olayan Center for Cancer Vaccines (Olayan CCV) and….
0
7
0
RT @thebetterindia: Pancreatic cancer — a disease with a 90% mortality rate — has long been a grim diagnosis. But that may be changing. Me….
0
11
0
I had a fun time chatting with @DKThomp about cancer vaccines. Check it out.
New pod: The science of cancer vaccines. Pancreatic is one of the deadliest cancers. In February, a New York lab found 75% of responders to its personalized mRNA cancer vaccine remained cancer-free at 3 years—a minor miracle. Today, Vinod Balachandran, the head of that lab,.
3
3
34
We are incredibly grateful for the support of The Marcus Foundation. This generous grant marks the beginning of an exciting new partnership to discover and advance next-generation cancer vaccines – we are excited about the possibilities ahead!.
The Marcus Foundation has awarded a generous grant to Dr. Vinod Balachandran (@TheVinodLab), Chief of the Olayan Center for Cancer Vaccines at MSK, to research next generation precision RNA vaccines for #pancreaticcancer. Learn more:
1
2
57
RT @JuliaBauman2: A new paper shows that personalized pancreatic cancer vaccines can keep patients cancer-free for YEARS - an incredible ou….
0
372
0
Great to chat with @scifri and @flichtman!. Link to audio below.
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine had no signs of relapse after three years. Dr. Vinod Balachandran joins us to discuss the results and what they could mean for cancer treatment.
0
7
16
2-4pm est on local public radio - fun chat on cancer vaccines w @scifri @flichtman 👇🏾. 🧵 👉🏾
sciencefriday.com
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
2
3
10
RT @TheMarkFdn: First, good news in the fight against #pancreaticcancer! ASPIRE awardee Ben Greenbaum (@bengrbm) of @MSKCancerCenter found….
nature.com
Nature - In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited...
0
9
0
RT @Nature: Nature research paper: RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer.
nature.com
Nature - In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited...
0
60
0
RT @PabloGuasp: I am excited to share our new work on personalized mRNA vaccines in pancreatic cancer in @Nature: G….
nature.com
Nature - In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited...
0
22
0
RT @celltherapynews: Hot off the press in @Nature! 🔥. Lead authors Zachary Sethna and @PabloGuasp and their colleagues show that autogene c….
0
8
0